Search for: "Ben Venue Laboratories, Inc."
Results 1 - 14
of 14
Sorted by Relevance
|
Sort by Date
13 May 2010, 4:44 pm
The companies, Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Roxane Inc., Ben Venue Laboratories Inc. and Roxane Laboratories Inc., are all affiliates of German drug giant, Boehringer Ingelheim GmbH. [read post]
7 Mar 2013, 6:37 am
Food and Drug Administration has really given Ben Venue Laboratories Inc. more chances than it ever deserved to get its act together. [read post]
2 Jul 2015, 12:06 pm
Hospira, Inc. cross-appeals the district court’s determination that the assert-ed claims are not invalid under the on-sale bar, obvious-ness, or indefiniteness.We conclude that the district court clearlyerred in finding that the bivalirudin batchesprepared by Ben Venue Laboratories before the criticaldate were not sold to The Medicines Company andwere prepared primarilyfor an experimental purpose. [read post]
10 Dec 2021, 12:37 pm
After thorough investigation and laboratory testing, the Utah Department of Health and Centers for Disease Control and Prevention (CDC) linked this outbreak to clover sprouts used by D&L to manufacture its sandwiches. [read post]
14 Jul 2016, 2:37 pm
(“MedCo”) did not sell Angiomax to the public before filing for the patents, but instead used a third-party contract manufacturing organization, Ben Venue Laboratories (“Ben Venue”), to ensure the drug met U.S. [read post]
31 Jan 2012, 6:13 am
Joe represents one of the successful moving defendants in the very recent decision that's described below.Take it away Joe:*****************On January 30, 2012, the United States District Court for the Eastern District of New York granted summary judgment in favor of Sandoz Inc., APP Pharmaceuticals, Inc., Ben Venue Laboratories, Inc., Teva Parenteral Medicines, Inc., and Hospira, Inc. with respect to all remaining… [read post]
13 Nov 2015, 1:40 pm
In the original opinion, penned by Judge Hughes and joined by Judges Dyk and Wallach, the Federal Circuit reversed a district validity determination — holding on appeal that the “district court clearly erred in finding that the bivalirudin batches prepared by Ben Venue Laboratories before the critical date were not sold to The Medicines Company and were prepared primarily for an experimental purpose. [read post]
15 Jun 2011, 4:56 am
Ben Venue Laboratories Inc. [read post]
10 Mar 2016, 6:01 am
The offer for sale was from the inventor’s vendor (Ben Venue Laboratories) to the inventor and his company. [read post]
7 Jul 2010, 4:18 pm
* Omri Ben-Shahar & Carl E. [read post]
5 May 2010, 10:14 pm
Ben Venue Labs., Inc., 271 F.3d 1043, 1046 (Fed. [read post]
28 Nov 2006, 4:11 pm
Ben Venue Labs., 246 F.3d 1368, 1378 (Fed. [read post]
13 Jul 2016, 4:21 pm
In so holding, the court vacated a previous Federal Circuit panel’s decision that MedCo’s asserted claims were invalid under § 102(b) based on transactions between MedCo (the Patentee) and a third-party manufacturing company, Ben Venue Laboratories (“BVL”), hired to manufacture batches of MedCo’s blood thinner drug Angiomax (bivalirudin). [read post]
20 Sep 2010, 7:28 am
Tree Top, Inc. uses large quantities of anhydrous ammonia at the plant as a refrigerant. [read post]
